Breaking News Instant updates and real-time market news.

NVS

Novartis

$83.27

0.11 (0.13%)

05:32
07/18/17
07/18
05:32
07/18/17
05:32

Novartis reports Q2 Core EPS $1.22, consensus $1.18

Reports Q2 revenue $12.24B, consensus $12.27B. Reports Q2 core operating profit $3.24B vs. $3.33B last year.

  • 18

    Jul

NVS Novartis
$83.27

0.11 (0.13%)

07/14/17
LEER
07/14/17
NO CHANGE
Target $36
LEER
Outperform
Leerink sees significant optionality for AstraZeneca beyond MYSTIC trial
Leerink analyst Seamus Fernandez said he sees significant optionality for AstraZeneca (AZN) beyond the "mega-catalyst" of the MYSTIC trial in non-small cell lung cancer, as he believes several 2017 and 2018 readouts from underappreciated pipeline assets could lead to upside for the shares. If MYSTIC fails, Astra's "massive" SG&A spend gives it flexibility to mute the bottom-line impact. If it is successful, he believes potential acquirers such as Pfizer (PFE) or Novartis (NVS) could see "an attractive target to plunder," Fernandez tells investors. He keeps an Outperform rating and $36 price target on AstraZeneca ADRs.
07/13/17
SBSH
07/13/17
NO CHANGE
SBSH
Novartis vote bodes well for Kite and Juno, says at Citi
Citi analyst Robyn Karnauskas believes the FDA's unanimous vote in favor of Novartis' (NVS) CAR-T bodes well for Kite Pharma (KITE) and Juno Therapeutics (JUNO). Yesterday's panel meeting provides a preview of what Kite can expect ahead of its November 29 FDA action date, Karnauskas tells investors in a research note. She believes the expert commentary from the panel has "overarching implications" for Kite and Juno, both of which are developing CAR-T therapies for multiple indications.
07/12/17
RHCO
07/12/17
NO CHANGE
Target $108
RHCO
Buy
bluebird bio recent weakness unwarranted, says SunTrust
SunTrust analyst Edward Nash views the weakness in bluebird bio (BLUE) shares since the FDA briefing document on Novartis' (NVSR) CAR T product candidate as unwarranted. The tone of the briefing document is neutral and emphasizes short-term toxicities observed in Novartis' studies and long-term safety concerns so that the Advisory Committee will be able to conduct a thorough discussion to determine the risk/benefit ratio, Nash tells investors in a research note. Further, he believes the data from Novartis and bluebird are not an apples-to-apples comparison and reminds investors of the "differentiated safety profile" that bluebird's bb2121 has demonstrated to date. He recommends buying bluebird on the recent selloff and reiterates a Buy rating on the name with a $108 price target.
07/10/17
JEFF
07/10/17
NO CHANGE
Target $121
JEFF
Buy
Jefferies ups Kite target to $121 on 'relatively benign' FDA docs
Jefferies analyst Biren Amin raised his price target for Kite Pharma (KITE) shares to $121 from $101 after the FDA posted briefing documents ahead of the July 12 committee meeting disusing Novartis' (NVS) CAR-T therapy CTL019. The documents for the first CAR-T therapy seem "relatively benign," Amin tells investors in a research note. The FDA's view of CAR-T therapies looks in-line with expectations, but the agency may require long-term follow-up of patients to assess for risk of secondary malignancies, Amin writes. He keeps a Buy rating on Kite Pharma. The stock in late morning trading is down 3% to $102.55.

TODAY'S FREE FLY STORIES

03:35
07/27/17
07/27
03:35
07/27/17
03:35
General news
FX Action: USD-CAD has traded yet lower »

FX Action: USD-CAD has…

02:25
07/27/17
07/27
02:25
07/27/17
02:25
General news
FX Update: The Fed's statement has put the dollar under the cosh »

FX Update: The…

01:30
07/27/17
07/27
01:30
07/27/17
01:30
General news
FX Action: USD-JPY logged a low at 110.78 »

FX Action: USD-JPY logged…

RETA

Reata Pharmaceuticals

$32.06

-0.46 (-1.41%)

22:11
07/26/17
07/26
22:11
07/26/17
22:11
Syndicate
Reata Pharmaceuticals 3.25M share Secondary priced at $31.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Jul

SNNA

Sienna Biopharmaceuticals

22:03
07/26/17
07/26
22:03
07/26/17
22:03
Syndicate
Sienna Biopharmaceuticals 4.3M share IPO priced at $15.00 »

The deal priced between…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

PG

Procter & Gamble

$89.30

0.16 (0.18%)

, BUD

AB InBev

$115.71

1.75 (1.54%)

20:25
07/26/17
07/26
20:25
07/26/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$89.30

0.16 (0.18%)

BUD

AB InBev

$115.71

1.75 (1.54%)

CMCSA

Comcast

$39.35

-0.4 (-1.01%)

CMCSK

Comcast

VZ

Verizon

$44.40

0.42 (0.95%)

MO

Altria Group

$71.73

-0.51 (-0.71%)

CELG

Celgene

$137.75

1.31 (0.96%)

CHTR

Charter

$348.77

0.77 (0.22%)

UPS

UPS

$112.29

-0.93 (-0.82%)

BMY

Bristol-Myers

$55.98

0.03 (0.05%)

DOW

Dow Chemical

$66.42

-0.43 (-0.64%)

COP

ConocoPhillips

$43.70

0.05 (0.11%)

RTN

Raytheon

$168.88

-0.71 (-0.42%)

ADP

ADP

$105.98

2.8 (2.71%)

JCI

Johnson Controls

$43.32

-0.86 (-1.95%)

LUV

Southwest

$59.52

0.7 (1.19%)

MCK

McKesson

$166.35

-1.28 (-0.76%)

PCG

PG&E

$67.90

0.39 (0.58%)

VLO

Valero

$67.99

-0.45 (-0.66%)

ALXN

Alexion

$131.07

1.72 (1.33%)

ZBH

Zimmer Biomet

$128.70

-0.07 (-0.05%)

MGM

MGM Resorts

$33.87

-0.4 (-1.17%)

DPS

Dr Pepper Snapple

$92.15

0.26 (0.28%)

KKR

KKR

$19.31

-0.15 (-0.77%)

TWTR

Twitter

$19.61

-0.36 (-1.80%)

LLL

L3 Technologies

$175.52

-1.79 (-1.01%)

NLSN

Nielsen

$39.89

1.27 (3.29%)

DNKN

Dunkin' Brands

$52.52

-0.71 (-1.33%)

WIX

Wix.com

$76.85

0.9 (1.19%)

TREE

LendingTree

$183.80

-2.25 (-1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 27

    Jul

  • 30

    Jul

  • 02

    Aug

  • 06

    Aug

  • 07

    Aug

  • 07

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 10

    Aug

  • 14

    Aug

  • 21

    Aug

  • 29

    Aug

  • 30

    Aug

  • 11

    Sep

  • 13

    Sep

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 23

    Oct

  • 09

    Nov

  • 05

    Mar

DISCA

Discovery

$26.58

0.65 (2.51%)

, SNI

Scripps Networks

$84.07

2.62 (3.22%)

19:33
07/26/17
07/26
19:33
07/26/17
19:33
Periodicals
Discovery in lead to buy Scripps, Reuters says »

Discovery (DISCA) has…

DISCA

Discovery

$26.58

0.65 (2.51%)

SNI

Scripps Networks

$84.07

2.62 (3.22%)

VIA

Viacom

$39.75

-0.6 (-1.49%)

VIAB

Viacom

$34.37

-0.64 (-1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 09

    Aug

VIA

Viacom

$39.75

-0.6 (-1.49%)

, VIAB

Viacom

$34.37

-0.64 (-1.83%)

19:30
07/26/17
07/26
19:30
07/26/17
19:30
Periodicals
Breaking Periodicals news story on Viacom, Viacom »

Viacom drops bidding for…

VIA

Viacom

$39.75

-0.6 (-1.49%)

VIAB

Viacom

$34.37

-0.64 (-1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

DISCA

Discovery

$26.58

0.65 (2.51%)

, SNI

Scripps Networks

$84.07

2.62 (3.22%)

19:28
07/26/17
07/26
19:28
07/26/17
19:28
Periodicals
Discovery offer for Scripps deemed superior to Viacom's, CNBC's Faber says »

Scripps (SNI) will enter…

DISCA

Discovery

$26.58

0.65 (2.51%)

SNI

Scripps Networks

$84.07

2.62 (3.22%)

VIA

Viacom

$39.75

-0.6 (-1.49%)

VIAB

Viacom

$34.37

-0.64 (-1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 09

    Aug

CRAY

Cray

$18.60

-0.3 (-1.59%)

, STX

Seagate

$32.34

-0.86 (-2.59%)

19:18
07/26/17
07/26
19:18
07/26/17
19:18
Hot Stocks
Cray, Seagate enter partnership centered around ClusterStor »

Cray (CRAY) announced it…

CRAY

Cray

$18.60

-0.3 (-1.59%)

STX

Seagate

$32.34

-0.86 (-2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

MDXG

MiMedx

$14.65

-0.22 (-1.48%)

19:18
07/26/17
07/26
19:18
07/26/17
19:18
Earnings
MiMedx backs FY17 adjusted EPS view of 31c-33c, consensus 30c »

Raises FY17 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 13

    Nov

  • 14

    Nov

MDXG

MiMedx

$14.65

-0.22 (-1.48%)

19:17
07/26/17
07/26
19:17
07/26/17
19:17
Earnings
Breaking Earnings news story on MiMedx »

MiMedx sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 13

    Nov

  • 14

    Nov

MDXG

MiMedx

$14.65

-0.22 (-1.48%)

19:16
07/26/17
07/26
19:16
07/26/17
19:16
Earnings
MiMedx reports Q2 EPS 7c, consensus 7c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 13

    Nov

  • 14

    Nov

GE

General Electric

$25.59

0.15 (0.59%)

, AEP

American Electric

$69.45

0.61 (0.89%)

19:08
07/26/17
07/26
19:08
07/26/17
19:08
Hot Stocks
Invenergy, GE to build 2,000 megawatt wind farm in Oklahoma »

Invenergy, along with GE…

GE

General Electric

$25.59

0.15 (0.59%)

AEP

American Electric

$69.45

0.61 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 02

    Oct

PSA

Public Storage

$210.06

2.34 (1.13%)

19:05
07/26/17
07/26
19:05
07/26/17
19:05
Earnings
Pure Storage reports Q2 core FFO $2.51, consensus $2.54 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

BRK.A

Berkshire Hathaway

$259,600.00

189.98 (0.07%)

, BRK.B

Berkshire Hathaway

$173.02

0.08 (0.05%)

18:57
07/26/17
07/26
18:57
07/26/17
18:57
Periodicals
Breaking Periodicals news story on Berkshire Hathaway, Berkshire Hathaway »

Elliott wins short delay…

BRK.A

Berkshire Hathaway

$259,600.00

189.98 (0.07%)

BRK.B

Berkshire Hathaway

$173.02

0.08 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXTI

AXT, Inc.

$7.60

0.25 (3.40%)

18:43
07/26/17
07/26
18:43
07/26/17
18:43
Earnings
AXT, Inc. sees Q3 EPS 8c-10c, consensus 7c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 03

    Aug

  • 10

    Aug

  • 19

    Sep

NGD

New Gold

$3.17

0.15 (4.97%)

18:42
07/26/17
07/26
18:42
07/26/17
18:42
Hot Stocks
New Gold names Paula Myson as CFO »

Myson has over 25 years…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

NGD

New Gold

$3.17

0.15 (4.97%)

18:40
07/26/17
07/26
18:40
07/26/17
18:40
Earnings
New Gold reports Q2 adjusted EPS 2c, consensus 2c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

PKG

Packaging Corp.

$108.80

0.22 (0.20%)

18:37
07/26/17
07/26
18:37
07/26/17
18:37
Earnings
Packaging Corp. sees Q3 EPS $1.68, consensus $1.66 »

Looking ahead to the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 12

    Sep

PKG

Packaging Corp.

$108.80

0.22 (0.20%)

18:36
07/26/17
07/26
18:36
07/26/17
18:36
Earnings
Packaging Corp. reports Q2 adjusted EPS $1.52, consensus $1.47 »

Reports Q2 revenue $1.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 12

    Sep

CUBI

Customers Bancorp

$28.24

-0.25 (-0.88%)

18:31
07/26/17
07/26
18:31
07/26/17
18:31
Hot Stocks
Customers Bank expands private, commercial banking unit into Chicago »

Customers Bank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

HNHPF

Hon Hai Precision

$7.70

-0.02 (-0.26%)

18:21
07/26/17
07/26
18:21
07/26/17
18:21
Hot Stocks
White House welcomes Foxconn announcement of LCD panel plant in Wisconsin »

President Donald J. Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFBK

Northfield Bancorp

$16.69

-0.34 (-2.00%)

18:15
07/26/17
07/26
18:15
07/26/17
18:15
Earnings
Northfield Bancorp reports Q2 EPS 18c, consensus 16c »

Net interest income for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

TXN

Texas Instruments

$82.53

1.14 (1.40%)

18:10
07/26/17
07/26
18:10
07/26/17
18:10
Periodicals
Texas Instruments' strong results, outlook signal further upside, Barron's says »

Texas Instruments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.